ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Trevicta 175 mg/0.875 ml, Depot-Injektionssuspension in einer Fertigspritze - 
66054001 Janssen-Cilag AG
Trevicta 175 mg/0.875 ml, Depot-Injektionssuspension in einer Fertigspritze16.11.2016
  16.11.2016
Paliperidone (N05AX13) 
WHO-DDD 
01.05. 
01.05. 
B  
Yes 
IP 
666.22No
    
10 %740.95
  
7680660540011Synthetika
6869609 
Composition
paliperidonum 175 mg ut paliperidoni palmitas 273 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 0.875 ml corresp. natrium 3.59 mg.
Packungsbestandteile
Retardsuspension zur intramuskulären Injektion 
  
 
Active AgentDose
Paliperidonum175mg / 0.875ml
BAG: Active AgentDose
Paliperidonum175 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Macrogol4000
Sodium Dihydrogenophosphate Monohydrate 
Sodium Hydroxide 
Polysorbatum 20 
 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home